ArticleJournal of anaesthesiology, clinical pharmacology
Goal-directed fluid therapy for endovascular therapeutic procedures in patients with aneurysmal subarachnoid hemorrhage: A pilot study.
Article in Journal of anaesthesiology, clinical pharmacology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Hypovolemia and hypotension are the main risk factors for the development of vasospasm or delayed cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage (aSAH). We aimed to compare the duration of hypovolemia and hypotension between goal-directed fluid therapy (GDFT) and standard fluid therapy (SFT) in patients undergoing endovascular therapeutic procedures for aSAH. Material and Methods: Twenty patients were enrolled in this single-center, prospective, randomized controlled, and double-blind study. Patients were randomized into the GDFT group ( Results: The demographic profile was comparable between both the groups. Fifty percent of the study population was hypovolemic before the procedure. The total duration of hypovolemia and hypotension [median (minimum-maximum)] was 3.66 min (0-10.66) and 4 (0-30) min ( Conclusions: Preprocedural hypovolemia is prevalent among patients scheduled for endovascular therapeutic procedures for aSAH. Duration of intraprocedural hypovolemia and duration of hypotension is comparable between GDFT and SFT groups in patients undergoing endovascular therapeutic procedures for aSAH. Hence, GDFT offers no distinctive advantage over SFT and should be individualized to specific patient needs (and not generalized to all the patients) undergoing endovascular therapeutic procedures for aSAH.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.